Kang I, Theodoropoulos G, Wangpaichitr M
Front Oncol. 2025; 14:1524651.
PMID: 39911818
PMC: 11794083.
DOI: 10.3389/fonc.2024.1524651.
Godfroid C, Romero J, Labiano S, Chuang C, Kelemen A, Wyss T
J Immunother Cancer. 2025; 13(1).
PMID: 39848686
PMC: 11759878.
DOI: 10.1136/jitc-2024-009832.
Bannwart F, Richter L, Stifel S, Rueter J, Lode H, Correia J
J Med Chem. 2024; 67(17):15494-15508.
PMID: 39196554
PMC: 11403678.
DOI: 10.1021/acs.jmedchem.4c01117.
Bernkop-Schnurch A, Hermann M, Leitner D, Talasz H, Descher H, Hohloch S
ACS Omega. 2024; 9(33):35394-35407.
PMID: 39184483
PMC: 11340086.
DOI: 10.1021/acsomega.4c01314.
Gao T, Liu W, Ma D, Huang W, Zhang D, Wei Q
Sci Rep. 2024; 14(1):18730.
PMID: 39134576
PMC: 11319440.
DOI: 10.1038/s41598-024-69357-9.
Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics.
Zhang J, Wu L, Su T, Liu H, Jiang L, Jiang Y
Front Endocrinol (Lausanne). 2024; 15:1365321.
PMID: 38779454
PMC: 11109426.
DOI: 10.3389/fendo.2024.1365321.
Progress in site-specific cancer mortality in Canada over the last 70 years.
Warkentin M, Ruan Y, Ellison L, Billette J, Demers A, Liu F
Sci Rep. 2024; 14(1):5688.
PMID: 38454087
PMC: 10920803.
DOI: 10.1038/s41598-024-56150-x.
Platinum-based drugs and hydrogel: a promising anti-tumor combination.
Yao J, Song S, Zhao H, Yuan Y
Drug Deliv. 2023; 30(1):2287966.
PMID: 38083803
PMC: 10987050.
DOI: 10.1080/10717544.2023.2287966.
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era.
Rossino G, Marchese E, Galli G, Verde F, Finizio M, Serra M
Molecules. 2023; 28(20).
PMID: 37894644
PMC: 10609221.
DOI: 10.3390/molecules28207165.
Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy.
Guijarro-Eguinoa J, Arjona-Hernandez S, Stewart S, Pernia O, Arias P, Losantos-Garcia I
Int J Mol Sci. 2023; 24(12).
PMID: 37372990
PMC: 10298094.
DOI: 10.3390/ijms24129843.
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer.
Wu C, Spector S, Theodoropoulos G, Nguyen D, Kim E, Garcia A
Cancer Metab. 2023; 11(1):7.
PMID: 37226257
PMC: 10207715.
DOI: 10.1186/s40170-023-00307-1.
Cancer Nanobombs Delivering Artoxplatin with a Polyigniter Bearing Hydrophobic Ferrocene Units Upregulate PD-L1 Expression and Stimulate Stronger Anticancer Immunity.
Gao Y, Zhang H, Tang L, Li F, Yang L, Xiao H
Adv Sci (Weinh). 2023; 11(4):e2300806.
PMID: 37166035
PMC: 10811492.
DOI: 10.1002/advs.202300806.
Platinum-based combination nanomedicines for cancer therapy.
Li Y, Lin W
Curr Opin Chem Biol. 2023; 74:102290.
PMID: 36989943
PMC: 10225318.
DOI: 10.1016/j.cbpa.2023.102290.
Concomitant delivery of doxorubicin and cisplatin through liposome-based thermosensitive nanoparticles: perspective in the treatment of cancer in animal models.
Maswadeh H, Khan A, Alorainy M, Al-Wabel N, Demetzos C
Am J Cancer Res. 2023; 13(2):379-393.
PMID: 36895979
PMC: 9989622.
Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH)(phterpy)] Complex.
Canil G, Gurruchaga-Pereda J, Braccini S, Marchetti L, Funaioli T, Marchetti F
Int J Mol Sci. 2023; 24(2).
PMID: 36674620
PMC: 9864011.
DOI: 10.3390/ijms24021106.
Yishen Xiezhuo formula ameliorates the development of cisplatin-induced acute kidney injury by attenuating renal tubular epithelial cell senescence.
Zhang Q, Qi J, Luo Q, Wu M, Zhang L, Qin L
Ann Transl Med. 2023; 10(24):1392.
PMID: 36660714
PMC: 9843381.
DOI: 10.21037/atm-22-5415.
Bone-Marrow-Derived Mesenchymal Stem Cells, Their Conditioned Media, and Olive Leaf Extract Protect against Cisplatin-Induced Toxicity by Alleviating Oxidative Stress, Inflammation, and Apoptosis in Rats.
Ibrahim M, Khalifa A, Mohamed A, Galhom R, Korayem H, Abd El-Fadeal N
Toxics. 2022; 10(9).
PMID: 36136492
PMC: 9504158.
DOI: 10.3390/toxics10090526.
The Synthesis, Characterization, Molecular Docking and In Vitro Antitumor Activity of Benzothiazole Aniline (BTA) Conjugated Metal-Salen Complexes as Non-Platinum Chemotherapeutic Agents.
Kamrul Islam M, Ha S, Baek A, Yang B, Kim Y, Park H
Pharmaceuticals (Basel). 2022; 15(6).
PMID: 35745670
PMC: 9228978.
DOI: 10.3390/ph15060751.
Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with , Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues.
Hildebrandt J, Hafner N, Gorls H, Barth M, Durst M, Runnebaum I
Int J Mol Sci. 2022; 23(12).
PMID: 35743112
PMC: 9224311.
DOI: 10.3390/ijms23126669.
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics.
Ferraro M, Piccolo M, Misso G, Santamaria R, Irace C
Pharmaceutics. 2022; 14(5).
PMID: 35631543
PMC: 9147010.
DOI: 10.3390/pharmaceutics14050954.
